Variables | Time | The effective group (n = 66) | The non-effective group (n = 26) | t | P |
---|---|---|---|---|---|
Galectin-3 (n) | Before treatment | 25.39 ± 3.21 | 31.29 ± 3.12 | − 8.000 | < 0.001 |
After treatment | 15.27 ± 3.03 | 19.27 ± 3.09 | − 5.670 | < 0.001 | |
RDW (fL) | Before treatment | 45.39 ± 3.21 | 48.48 ± 3.09 | − 4.200 | < 0.001 |
After treatment | 41.28 ± 3.12 | 44.73 ± 3.02 | − 4.818 | < 0.001 | |
Hepc (ng/mL) | Before treatment | 93.02 ± 9.87 | 102.98 ± 9.12 | − 4.449 | < 0.001 |
After treatment | 57.27 ± 9.12 | 66.35 ± 9.01 | − 4.314 | < 0.001 | |
HS (μg/L) | Before treatment | 191.98 ± 8.32 | 199.39 ± 8.28 | − 3.852 | < 0.001 |
After treatment | 179.28 ± 7.66 | 185.31 ± 7.83 | − 3.379 | 0.001 | |
Ferritin (ng/mL) | Before treatment | 28.93 ± 12.12 | 23.02 ± 11.87 | 2.118 | 0.037 |
After treatment | 117.98 ± 13.02 | 109.98 ± 12.98 | 2.656 | 0.009 |